The latest news from the global pharmaceutical industry. Below you will find news and information to keep you up-to-date with what is happening in your industry. Coverage includes regulatory approvals, recall announcements, mergers and acquisitions, personnel news and appointments, new facility and facility expansion updates, collaborations and agreements, and financial updates.
Wednesday, March 01, 2023
The FDA announced that it has taken action to restrict the unlawful entry of xylazine active pharmaceutical ingredients and finished dosage form drug ...
read more
Tuesday, January 10, 2023
Spectrum Laboratory Products, Inc. is voluntarily recalling three lots of Epinephrine (L-Adrenaline) USP, a bulk active pharmaceutical ingredient (API...
read more
Orchard Therapeutics announced the FDA cleared its Investigational New Drug (IND) application for OTL-203, a hematopoietic stem cell (HSC) gene ...
read more
Monday, November 21, 2022
The US FDA issued warning letters to seven companies for illegally selling dietary supplements that claim to cure, treat, mitigate or prevent ...
read more
Friday, November 11, 2022
AstraZeneca announced the availability of the first rare disease therapy from Alexion, AstraZeneca’s Rare Disease group, in China. The availability of...
read more
Wednesday, November 09, 2022
The FDA Pulmonary-Allergy Drugs Advisory Committee (PADAC) has voted 16 to 1 that the data support a favorable benefit risk assessment for the use of ...
read more
Thursday, October 20, 2022
AAPS will be the exclusive authority advising RX on scientific focus areas that affect the approximate 8,000-person event beginning in spring 2023 ...
read more
Wednesday, September 21, 2022
Novartis announced that the U.S. Court of Appeals for the Federal Circuit (CAFC) has denied its petition to rehear the negative decision regarding the...
read more
Wednesday, September 14, 2022
Following their recent expansion into formulation, method and lyo development, Berkshire Sterile Manufacturing (BSM) now offers two new services to ...
read more
Sartorius agreed to acquire Albumedix from private investors. The Nottingham, UK-based company provides recombinant albumin-based solutions.
read more
Novavax announced the initiation of its Phase 2b/3 Hummingbird™ clinical trial. The trial will evaluate the safety, effectiveness (immunogenicity), ...
read more
3M announced a spin off of its Health Care business. This results in two world-class public companies positioned to pursue distinct growth plans. The ...
read more
Soleo Health is now a limited distribution partner for the cardiovascular drug LEQVIO®, manufactured by Novartis.
read more
PTI – Packaging Technologies & Inspection, a New York-based solutions provider of package testing equipment, acquired St. Prex, Switzerland based ...
read more
The Canadain Government has signed a new contract with GlaxoSmithKline to support sustained influenza pandemic readiness.
read more